HC Deb 10 December 1996 vol 287 cc151-2W
Mr. Gordon Prentice

To ask the Secretary of State for Health how much has been allocated to support research into the causes and treatment of MS in each year since 1990. [7804]

Mr. Malone

Funding specifically on multiple sclerosis from the Department of Health and the Medical Research Council since 1990 appears in the table.

  • 1989–90: £182,000
  • 1990–91: £181,000
  • 1991–92: £80,000
  • 1992–93: £64,000
  • 1993–94: £154,000
  • 1994–95: £207,000
  • 1995–96: £216,000.

Note: The MRC also undertakes work under the broader headings of autoimmune disorders and diseases of the central nervous system (£6,280,000 in 1995–96), and neurodegenerative diseases, all of which underpin research into MS.

Mr. Prentice

To ask the Secretary of State for Health if he will list the amount allocated by each health authority in England to(a) beta-interferon and (b) other drugs used in the treatment of people with MS for the most recent available year; and what sums were spent. [7805]

Mr. Malone

Information is not collected centrally on the amounts allocated for beta-interferon or other individual drugs by individual health authorities.

I refer the hon. Member to my response to the hon. Member for York (Mr. Bayley) on 4 November, column 404 for the latest information on spending on beta-interferon drugs. It is not possible to identify the amount spent on other drugs used in the treatment of patients with multiple sclerosis.

Forward to